JMI-105 is a potent inhibitor of PfFP-2 (Plasmodium falciparum falcipain-2) and exhibits antiplasmodial activity against both chloroquine-sensitive (CQS, 3D7; IC50 = 8.8 µM) and chloroquine-resistant (CQR, RKL-9; IC50 = 14.3 µM) strains of Plasmodium falciparum; it significantly reduces parasitemia and prolongs host survival in a Plasmodium berghei ANKA mouse model, demonstrating potential as an antimalarial agent.